InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,430.40
(
0.14%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.58
(
-0.14%
)
Bitcoin
65,218.48
(
0.39%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (6) Keep Next 10 Report Keyboard Shortcuts
Replies (6) Next 10 Prev Next

Jesspro

Send PM Follow Ignore
Followers 41
Posts 6068
Boards Moderated 1
Alias Born 06/29/2011

Jesspro

Re: None

Friday, 02/14/2014 4:22:30 PM

Friday, February 14, 2014 4:22:30 PM

Post# of 80490
Adam Feurstein again is the center of drama at GALE Pharmaceuticals. His articles probably are no longer effective at ARIAD, so he moved on to another up and coming biotech. Whatever you think about him, he can move mountains. It's so unbelievable that one man's pen can create havoc and affect billions of dollars, thousands of patients, and untold miseries for thousands of small investors. I hope he doesn't return here. Read for yourself.

http://finance.yahoo.com/news/galena-biopharma-issues-letter-shareholders-202405084.html
Public Reply Private Reply New Post
Keep Last Read
Replies (6) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (6) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up